Clinical Trial Update: Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating dronedarone added to standard therapy in patients with permanent atrial fibrillation was terminated early; results posted in 2012, hi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Multaq (dronedarone)

Snippet

Sponsor: Sanofi | Conditions: Atrial Fibrillation | Phase 3 | Status: TERMINATED | Results posted: 2012-10-26